Effects of Thermal Stimulation on Motor Recovery and Neuromuscular Property of Lower Extremity in Stroke
Neurorehabilitation Lab at Department of Physical Therapy in KMU
1 other identifier
interventional
37
1 country
1
Brief Summary
This 3-year study will recruit a total of 72 subjects with first-ever stroke after 3 months onset from the department of Physical Medicine and Rehabilitation in 3 teaching hospitals. This study design employs a prospective single-blinded, randomized controlled trial with pretest, posttest, and follow-up assessments. Participants who meet and be willing to join this study will be assigned into one of three groups (noxious cold only, noxious heat only, or alternative TS). All subjects will receive conventional rehabilitation. In addition, three groups will receive an additional TS protocol with a total of 15 sessions for 3 weeks (5 times per week, 30 minutes daily). Primary outcome measures include the LE subscale of Fugl-Meyer assessment, the modified Ashworth scale, the Postural Assessment Scale for Stroke Patients, Timed Up and Go test, and the Barthel index. Moreover, spinal circuit excitability will be assessed by measuring Hoffmann reflex/ M wave ratio, H-reflex recruitment curves, and reciprocal inhibition of the soleus muscle. Muscle properties will be evaluated by measuring the soleus muscle tone, elasticity, and stiffness. All participants will be assessed with the outcome measures at beginning of the intervention, the end of the intervention, 1 month and 3 months after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2020
CompletedStudy Start
First participant enrolled
March 9, 2020
CompletedFirst Posted
Study publicly available on registry
March 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 24, 2023
CompletedNovember 18, 2023
November 1, 2023
3.4 years
March 8, 2020
November 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
The Lower Extremity subscale of Fugl-Meyer assessment (FMA-LE)
The FMA-LE consists of 17 items, each scored on a 3-point scale (0 to 2). The total score of the FMA-LE ranges from 0 to 34, and higher scores indicate better motor performance.
Change from the beginning of the intervention to the end of the intervention, 1 month and 3 months after the intervention.
The Postural Assessment Scale for Stroke (PASS)
The PASS is a 4-point rating (0 to 3) scale with well-established reliability and validity that measures balance function in persons with stroke. The total score of the PASS ranges from 0 to 36, and higher scores indicate greater balance function.
Change from the beginning of the intervention to the end of the intervention, 1 month and 3 months after the intervention.
The modified Ashworth scale (MAS)
The modified Ashworth scale is a 6-point rating scale (0 to 5) with well-established inter-rater reliability that measures muscle tone of ankle plantarflexor in persons with stroke. Higher MAS scores indicate greater severity of spasticity.
Change from the beginning of the intervention to the end of the intervention, 1 month and 3 months after the intervention.
The Barthel index (BI)
The Barthel index is used to evaluate activity of daily living function.The Barthel index consists of 10 items. The total score of the Barthel index ranges from 0 to 20, and higher scores indicate better outcome.
Change from the beginning of the intervention to the end of the intervention, 1 month and 3 months after the intervention.
Timed up and go test(TUG)
The Timed Up and Go (TUG) test assesses mobility by measuring the time it takes for someone to stand, walk a short distance, turn, and sit back down. Faster times suggest better mobility, while longer times may indicate mobility limitations or fall risk. It's a useful tool to evaluate functional capacity and guide interventions for improved mobility.
Change from the beginning of the intervention to the end of the intervention, 1 month and 3 months after the intervention.
Secondary Outcomes (2)
Spinal circuit excitability
Change from the beginning of the intervention to the end of the intervention, 1 month and 3 months after the intervention.
Muscle properties
Change from the beginning of the intervention to the end of the intervention, 1 month and 3 months after the intervention.
Study Arms (3)
noxious cold group
ACTIVE COMPARATORThe group received noxious cold (3 - 4°C) stimuli on the affected leg for 30 minutes.
noxious heat group
ACTIVE COMPARATORThe group received noxious heat (46 - 47°C) stimuli on the affected leg for 30 minutes.
alternative thermal stimulation group
ACTIVE COMPARATORThe group received alternative noxious heat (46 - 47°C) and noxious cold (3 - 4°C) stimuli on the affected leg for 30 minutes.
Interventions
The protocol included range of motion, ambulation, endurance, strengthening, reconditioning exercise, and home program education according to therapists' plans and the patients' ability.
Eligibility Criteria
You may qualify if:
- Willing to participate to this study with written informed consent
- First-ever stroke
- More six months after stroke onset
- Ability to maintain an independent sitting posture for at least 30 minutes
- Mini Mental Status Examination score more than 24
You may not qualify if:
- Skin disease, skin injuries, burns, or fresh scars over the thermal stimulation application area
- Contraindication of ice or heat application
- Uncontrolled blood pressure and heart conditions
- History of diabetes with known peripheral vascular pathology
- Pregnancy
- Unable to communicate with simple instruction or aphasia
- Receiving Botulinum toxin drug treatment
- Considered as unsuitable by the principal investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Medical University Hospital
Kaohsiung City, Select One..., 886807, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jau-Hong Lin, PhD
Department of Physical Therapy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 8, 2020
First Posted
March 12, 2020
Study Start
March 9, 2020
Primary Completion
July 31, 2023
Study Completion
October 24, 2023
Last Updated
November 18, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share